Records containing: Mucopolysaccharidosis VI
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-08Registry of Patients Diagnosed With Lysosomal Storage Diseases
-
CLINICAL_TRIALS study record update · 2026-02-11Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics
-
CLINICAL_TRIALS study record update · 2026-02-02Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II, and VI
-
CLINICAL_TRIALS study record update · 2025-09-12ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
-
CLINICAL_TRIALS study record update · 2025-08-12Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-12-19A Randomized Clinical Trial to Evaluate the Effects of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
-
CLINICAL_TRIALS study record update · 2022-10-25A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders
-
CLINICAL_TRIALS study record update · 2019-11-01A Phase IIa Study to Investigate Safety, Pharmacokinetics, and Efficacy of Odiparcil in Patients 16 Years and Above With Mucopolysaccharidosis (MPS) Type VI
-
CLINICAL_TRIALS study record update · 2015-08-04Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
-
CLINICAL_TRIALS study record update · 2014-11-24Phase II/III, Randomized, Clinical Trial of the Effects of Nutropin AQ® on Growth and Bone Metabolism in Children With MPS I, II, and VI and Short Stature
-
CLINICAL_TRIALS study record update · 2013-05-24Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
-
CLINICAL_TRIALS study record update · 2010-10-15A Phase 4 Multi-center, Multi-national, Open-label, Randomized, Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With Maroteaux-Lamy Syndrome (MPS VI)
-
CLINICAL_TRIALS study record update · 2009-09-04Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)
-
CLINICAL_TRIALS study record update · 2009-08-25Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI
-
CLINICAL_TRIALS study record update · 2009-08-17ClinicalTrials.gov study NCT00067470
-
CLINICAL_TRIALS study record update · 2009-03-06A Multicenter, Multinational Open-Label Extension Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With Mucopolysaccharidosis VI
-
CLINICAL_TRIALS study record update · 2006-11-03Double-Blind,2 Dose Group Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI